Literature DB >> 6812716

A case of Lassa fever: clinical and virological findings.

R T Emond, B Bannister, G Lloyd, T J Southee, E T Bowen.   

Abstract

Five days after arriving in London from Jos a young Nigerian women developed a severe and prolonged illness that proved to be Lassa fever. Virus was not detected in urine during the first three weeks but then appeared and reached a peak during the sixth week, with continuing excretion for 67 days after the onset of illness. Laboratory investigations showed evidence of extensive tissue damage and disturbance of clotting, but there was no serious bleeding and she eventually made a complete recovery despite a high sustained viraemia and severe liver damage. Convalescent serum was used in treatment but it was difficult to assess its contribution to the favourable outcome.

Entities:  

Mesh:

Year:  1982        PMID: 6812716      PMCID: PMC1500383          DOI: 10.1136/bmj.285.6347.1001

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  6 in total

1.  Negative-pressure plastic isolator for patients with dangerous infections.

Authors:  P C Trexler; R T Emond; B Evans
Journal:  Br Med J       Date:  1977-08-27

2.  Lassa fever in Panguma Hospital, Sierra Leone, 1973-6.

Authors:  E Keane; H M Gilles
Journal:  Br Med J       Date:  1977-05-28

3.  Lassa immune serum.

Authors:  A J Clayton
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

4.  Public health aspects of viral haemorrhagic fevers in Britain.

Authors:  N S Galbraith; J R Berrie; P Forbes; S Young
Journal:  R Soc Health J       Date:  1978-08

5.  Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease.

Authors:  E Leifer; D J Gocke; H Bourne
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

6.  A case of Lassa fever: experience at St Thomas's Hospital.

Authors:  C B Cooper; W R Gransden; M Webster; M King; M O'Mahony; S Young; J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09
  6 in total
  11 in total

1.  Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever.

Authors:  Chad E Mire; Robert W Cross; Joan B Geisbert; Viktoriya Borisevich; Krystle N Agans; Daniel J Deer; Megan L Heinrich; Megan M Rowland; Augustine Goba; Mambu Momoh; Mathew L Boisen; Donald S Grant; Mohamed Fullah; Sheik Humarr Khan; Karla A Fenton; James E Robinson; Luis M Branco; Robert F Garry; Thomas W Geisbert
Journal:  Nat Med       Date:  2017-09-04       Impact factor: 53.440

2.  A case of Lassa fever: experience at St Thomas's Hospital.

Authors:  C B Cooper; W R Gransden; M Webster; M King; M O'Mahony; S Young; J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09

3.  International external quality assessment study for molecular detection of Lassa virus.

Authors:  Sergejs Nikisins; Toni Rieger; Pranav Patel; Rolf Müller; Stephan Günther; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2015-05-21

4.  The Lymphocytic Choriomeningitis Virus Matrix Protein PPXY Late Domain Drives the Production of Defective Interfering Particles.

Authors:  Christopher M Ziegler; Philip Eisenhauer; Emily A Bruce; Marion E Weir; Benjamin R King; Joseph P Klaus; Dimitry N Krementsov; David J Shirley; Bryan A Ballif; Jason Botten
Journal:  PLoS Pathog       Date:  2016-03-24       Impact factor: 6.823

Review 5.  Moving interdisciplinary science forward: integrating participatory modelling with mathematical modelling of zoonotic disease in Africa.

Authors:  Catherine Grant; Giovanni Lo Iacono; Vupenyu Dzingirai; Bernard Bett; Thomas R A Winnebah; Peter M Atkinson
Journal:  Infect Dis Poverty       Date:  2016-02-25       Impact factor: 4.520

6.  A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot.

Authors:  Louise Sigfrid; Catrin Moore; Alex P Salam; Nicola Maayan; Candyce Hamel; Chantelle Garritty; Vittoria Lutje; Brian Buckley; Karla Soares-Weiser; Rachel Marshall; Mike Clarke; Peter Horby
Journal:  BMC Med       Date:  2019-06-11       Impact factor: 8.775

7.  Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.

Authors:  Laura Merson; Josephine Bourner; Sulaiman Jalloh; Astrid Erber; Alex Paddy Salam; Antoine Flahault; Piero L Olliaro
Journal:  PLoS Negl Trop Dis       Date:  2021-09-21

8.  Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study.

Authors:  Solen Kernéis; Lamine Koivogui; N'Faly Magassouba; Kekoura Koulemou; Rosamund Lewis; Aristide Aplogan; Rebecca F Grais; Philippe J Guerin; Elisabeth Fichet-Calvet
Journal:  PLoS Negl Trop Dis       Date:  2009-11-17

9.  Management of a Lassa fever outbreak, Rhineland-Palatinate, Germany, 2016.

Authors:  Lutz Ehlkes; Maja George; Gerhard Samosny; Florian Burckhardt; Manfred Vogt; Stefan Bent; Klaus Jahn; Philipp Zanger
Journal:  Euro Surveill       Date:  2017-09

Review 10.  Find the right sample: A study on the versatility of saliva and urine samples for the diagnosis of emerging viruses.

Authors:  Matthias Niedrig; Pranav Patel; Ahmed Abd El Wahed; Regina Schädler; Sergio Yactayo
Journal:  BMC Infect Dis       Date:  2018-12-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.